No Data
Wells Fargo Adjusts Price Target on CVS Health to $61 From $60, Maintains Equalweight Rating
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Truist Financial Sticks to Their Buy Rating for CVS Health (CVS)
Hold Rating on CVS Health Amidst Anticipated Earnings Pressure and Segment Challenges
The U.S. Uninsured Rate Hits 8%, a Post-pandemic High
12 Out of 17 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard